Prognostic value and clinicopathological differences of HIFs in colorectal cancer: Evidence from meta-analysis

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Chen, Zhigang ^a   He, Xin ^a   Xia, Wenjie ^a   Huang, Qi ^a   Zhang, Zhigang ^a   Ye, Jun ^a   Ni, Chao ^a   Wu, Pin ^a   Wu, Dang ^a   Xu, Jinghong ^a   Qiu, Fuming ^a   Huang, Jian ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA;

ARTICLE; ASIAN; CANCER MORTALITY; CANCER PROGNOSIS; CANCER STAGING; CLINICAL FEATURE; COLORECTAL CANCER; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; ETHNIC DIFFERENCE; EUROPE; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; META ANALYSIS; OVERALL SURVIVAL; PROTEIN EXPRESSION; TUMOR DIFFERENTIATION; TUMOR INVASION;

ASIAN CONTINENTAL ANCESTRY GROUP; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; COLORECTAL NEOPLASMS; DATABASES, BIBLIOGRAPHIC; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE EXPRESSION; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; NEOPLASM GRADING; ODDS RATIO; PROGNOSIS; RISK; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84891918539     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0080337     Document Type: Article

References (39)

1. Siegel R, Naishadham D, Jemal A (2013) Cancer statistics, 2013. CA: A Cancer Journal for Clinicians 63: 11-30.
2. Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics, 2010. CA: A Cancer Journal for Clinicians 60: 277-300.
3. Griffiths EA, Pritchard SA, Valentine HR, Whitchelo N, Bishop PW, et al. (2007) Hypoxia-inducible factor-1alpha expression in the gastric carcinogenesis sequence and its prognostic role in gastric and gastro-oesophageal adenocarcinomas. British Journal of Cancer 96: 95-103. (Pubitemid 46094645)
4. Baba Y, Nosho K, Shima K, Irahara N, Chan AT, et al. (2010) HIF1A overexpression is associated with poor prognosis in a cohort of 731 colorectal cancers. American Journal of Pathology 176: 2292-2301.
5. Yoshimura H, Dhar DK, Kohno H, Kubota H, Fujii T, et al. (2004) Prognostic impact of hypoxia-inducible factors 1alpha and 2alpha in colorectal cancer patients: correlation with tumor angiogenesis and cyclooxygenase-2 expression. Clinical Cancer Research 10: 8554-8560. (Pubitemid 40053424)
6. Hu CJ, Wang LY, Chodosh LA, Keith B, Simon MC (2003) Differential roles of hypoxia-inducible factor 1alpha (HIF-1αlpha) and HIF-2αlpha in hypoxic gene regulation. Molecular and Cellular Biology 23: 9361-9374. (Pubitemid 37499822)
7. Mazumdar J, Hickey MM, Pant DK, Durham AC, Sweet-Cordero A, et al. (2010) HIF-2αlpha deletion promotes Kras-driven lung tumor development. Proceedings of the National Academy of Sciences of the United States of America 107: 14182-14187.
8. Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. European Journal of Epidemiology 25: 603-605.
9. Parmar MK, Torri V, Stewart L (1998) Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Statistics in Medicine 17: 2815-2834. (Pubitemid 28562978)
10. Handoll HH (2006) Systematic reviews on rehabilitation interventions. Archives of Physical Medicine and Rehabilitation 87: 875. (Pubitemid 43767714)
11. Ioannidis JP, Patsopoulos NA, Evangelou E (2007) Uncertainty in heterogeneity estimates in meta-analyses. BMJ 335: 914-916. (Pubitemid 350076978)
12. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. Journal of the National Cancer Institute 22: 719-748.
13. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327: 557-560. (Pubitemid 37088507)
14. Xie G, Zheng L, Ou J, Huang H, He J, et al. (2012) Low expression of prolyl hydroxylase 2 is associated with tumor grade and poor prognosis in patients with colorectal cancer. Exp Biol Med (Maywood) 237: 860-866.
15. Korkeila EA, Sundstrom J, Pyrhonen S, Syrjanen K (2011) Carbonic anhydrase IX, hypoxia-inducible factor-1alpha, ezrin and glucose transporter-1 as predictors of disease outcome in rectal cancer: multivariate Cox survival models following data reduction by principal component analysis of the clinicopathological predictors. Anticancer Research 31: 4529-4535.
16. Shioya M, Takahashi T, Ishikawa H, Sakurai H, Ebara T, et al. (2011) Expression of hypoxia-inducible factor 1alpha predicts clinical outcome after preoperative hyperthermo-chemoradiotherapy for locally advanced rectal cancer. J Radiat Res 52: 821-827.
17. Havelund BM, Sorensen FB, Lindebjerg J, Spindler KL, Jakobsen A (2011) Pretreatment HIF-1αlpha and GLUT-1 expressions do not correlate with outcome after preoperative chemoradiotherapy in rectal cancer. Anticancer Research 31: 1559-1565.
18. Kwon HC, Kim SH, Oh SY, Lee S, Kwon KA, et al. (2010) Clinicopathological significance of p53, hypoxia-inducible factor 1alpha, and vascular endothelial growth factor expression in colorectal cancer. Anticancer Research 30: 4163-4168.
19. Saigusa S, Tanaka K, Toiyama Y, Yokoe T, Okugawa Y, et al. (2011) Clinical significance of CD133 and hypoxia inducible factor-1alpha gene expression in rectal cancer after preoperative chemoradiotherapy. Clinical Oncology (Royal College of Radiologists) 23: 323-332.
20. Wu Y, Jin M, Xu H, Shimin Z, He S, et al. (2010) Clinicopathologic significance of HIF-1αlpha, CXCR4, and VEGF expression in colon cancer. Clin Dev Immunol 2010.
21. Zheng J, Sun X, Wang W, Lu S (2010) Hypoxia-inducible factor-1alpha modulates the down-regulation of the homeodomain protein CDX2 in colorectal cancer. Oncology Reports 24: 97-104.
22. Toiyama Y, Inoue Y, Saigusa S, Okugawa Y, Yokoe T, et al. (2010) Gene expression profiles of epidermal growth factor receptor, vascular endothelial growth factor and hypoxia-inducible factor-1 with special reference to local responsiveness to neoadjuvant chemoradiotherapy and disease recurrence after rectal cancer surgery. Clinical Oncology (Royal College of Radiologists) 22: 272-280.
23. Cao D, Hou M, Guan YS, Jiang M, Yang Y, et al. (2009) Expression of HIF- 1alpha and VEGF in colorectal cancer: association with clinical outcomes and prognostic implications. BMC Cancer 9: 432.
24. Jubb AM, Turley H, Moeller HC, Steers G, Han C, et al. (2009) Expression of delta-like ligand 4 (Dll4) and markers of hypoxia in colon cancer. British Journal of Cancer 101: 1749-1757.
25. Rajaganeshan R, Prasad R, Guillou PJ, Scott N, Poston G, et al. (2009) Expression patterns of hypoxic markers at the invasive margin of colorectal cancers and liver metastases. European Journal of Surgical Oncology 35: 1286-1294.
26. Schmitz KJ, Muller CI, Reis H, Alakus H, Winde G, et al. (2009) Combined analysis of hypoxia-inducible factor 1 alpha and metallothionein indicates an aggressive subtype of colorectal carcinoma. International Journal of Colorectal Disease 24: 1287-1296.
27. Rasheed S, Harris AL, Tekkis PP, Turley H, Silver A, et al. (2009) Hypoxiainducible factor-1alpha and -2alpha are expressed in most rectal cancers but only hypoxia-inducible factor-1alpha is associated with prognosis. British Journal of Cancer 100: 1666-1673.
28. Cleven AH, van Engeland M, Wouters BG, de Bruine AP (2007) Stromal expression of hypoxia regulated proteins is an adverse prognostic factor in colorectal carcinomas. Cell Oncol 29: 229-240. (Pubitemid 46855703)
29. Lu XG, Xing CG, Feng YZ, Chen J, Deng C (2006) Clinical significance of immunohistochemical expression of hypoxia-inducible factor-1alpha as a prognostic marker in rectal adenocarcinoma. Clin Colorectal Cancer 5: 350-353. (Pubitemid 43280065)
30. Theodoropoulos GE, Lazaris AC, Theodoropoulos VE, Papatheodosiou K, Gazouli M, et al. (2006) Hypoxia, angiogenesis and apoptosis markers in locally advanced rectal cancer. International Journal of Colorectal Disease 21: 248-257. (Pubitemid 43280332)
31. Kuwai T, Kitadai Y, Tanaka S, Onogawa S, Matsutani N, et al. (2003) Expression of hypoxia-inducible factor-1alpha is associated with tumor vascularization in human colorectal carcinoma. International Journal of Cancer 105: 176-181. (Pubitemid 36505317)
32. Mohammed N, Rodriguez M, Garcia V, Garcia JM, Dominguez G, et al. (2011) EPAS1 mRNA in plasma from colorectal cancer patients is associated with poor outcome in advanced stages. Oncol Lett 2: 719-724.
33. Hockel M, Knoop C, Schlenger K, Vorndran B, Baussmann E, et al. (1993) Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix. Radiotherapy and Oncology 26: 45-50. (Pubitemid 23063609)
34. Birner P, Gatterbauer B, Oberhuber G, Schindl M, Rossler K, et al. (2001) Expression of hypoxia-inducible factor-1 alpha in oligodendrogliomas: its impact on prognosis and on neoangiogenesis. Cancer 92: 165-171. (Pubitemid 32623053)
35. Bos R, van der Groep P, Greijer AE, Shvarts A, Meijer S, et al. (2003) Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma. Cancer 97: 1573-1581. (Pubitemid 36297788)
36. Shibaji T, Nagao M, Ikeda N, Kanehiro H, Hisanaga M, et al. (2003) Prognostic significance of HIF-1 alpha overexpression in human pancreatic cancer. Anticancer Research 23: 4721-4727. (Pubitemid 38173890)
37. Theodoropoulos VE, Lazaris A, Sofras F, Gerzelis I, Tsoukala V, et al. (2004) Hypoxia-inducible factor 1 alpha expression correlates with angiogenesis and unfavorable prognosis in bladder cancer. European Urology 46: 200-208. (Pubitemid 38902737)
38. Sutter CH, Laughner E, Semenza GL (2000) Hypoxia-inducible factor 1alpha protein expression is controlled by oxygen-regulated ubiquitination that is disrupted by deletions and missense mutations. Proc Natl Acad Sci U S A 97: 4748-4753. (Pubitemid 30238629)
39. Lidgren A, Hedberg Y, Grankvist K, Rasmuson T, Vasko J, et al. (2005) The expression of hypoxia-inducible factor 1alpha is a favorable independent prognostic factor in renal cell carcinoma. Clinical Cancer Research 11: 1129-1135. (Pubitemid 40175762)